 | • レポートコード：MRC23Q35825 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の生物製剤滅菌充填仕上げサービス市場について調査・分析し、世界の生物製剤滅菌充填仕上げサービス市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（バイアル、プレフィルドシリンジ、カートリッジ、その他）、用途別セグメント分析（ワクチン、バイオ医薬品、バイオシミラー、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Baxter BioPharma Solutions、Boehringer Ingelheim、Vetter Pharma、Fresenius Kabi、Pfizer CentreOne、Aenova、WuXi Biologics、Jubilant HollisterStier、Bushu Pharmaceuticals、LSNE Contract Manufacturing、Ajinomoto Bio-Pharma Services、CMIC CMO、GRAM (Grand River Aseptic Manufacturing)、TAIYO Pharma Tech Co.,Ltd.、HALIX、Cognate BioServices、Afton Scientific、Novasep、Emergent BioSolutions、Seikagaku、Jiangshu YAOHAI Bio-pharmaceutical、Akron Biotech、Symbiosis Pharmaceutical Services、Techdow、Vigene Biosciencesなどが含まれています。 世界の生物製剤滅菌充填仕上げサービス市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、生物製剤滅菌充填仕上げサービス市場規模を推定する際に考慮しました。本レポートは、生物製剤滅菌充填仕上げサービスの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、生物製剤滅菌充填仕上げサービスに関するビジネス上の意思決定に役立てることを目的としています。 ・生物製剤滅菌充填仕上げサービス市場の概要 - 生物製剤滅菌充填仕上げサービスのタイプ別セグメント - 世界の生物製剤滅菌充填仕上げサービス市場規模：タイプ別分析（バイアル、プレフィルドシリンジ、カートリッジ、その他） - 生物製剤滅菌充填仕上げサービスの用途別セグメント - 世界の生物製剤滅菌充填仕上げサービス市場規模：用途別分析（ワクチン、バイオ医薬品、バイオシミラー、その他） - 世界の生物製剤滅菌充填仕上げサービス市場規模予測（2018年-2029年） ・生物製剤滅菌充填仕上げサービス市場の成長トレンド - 生物製剤滅菌充填仕上げサービスの地域別市場規模（2018年-2029年） - 生物製剤滅菌充填仕上げサービス市場ダイナミクス - 生物製剤滅菌充填仕上げサービスの業界動向 - 生物製剤滅菌充填仕上げサービス市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：バイアル、プレフィルドシリンジ、カートリッジ、その他 - 世界の生物製剤滅菌充填仕上げサービスのタイプ別市場規模（2018年-2023年） - 世界の生物製剤滅菌充填仕上げサービスのタイプ別市場規模（2024年-2029年） ・用途別セグメント：ワクチン、バイオ医薬品、バイオシミラー、その他 - 世界の生物製剤滅菌充填仕上げサービスの用途別市場規模（2018年-2023年） - 世界の生物製剤滅菌充填仕上げサービスの用途別市場規模（2024年-2029年） ・生物製剤滅菌充填仕上げサービスの地域別市場規模 - 北米の生物製剤滅菌充填仕上げサービス市場規模（2018年-2029年） - アメリカの生物製剤滅菌充填仕上げサービス市場規模（2018年-2029年） - ヨーロッパの生物製剤滅菌充填仕上げサービス市場規模（2018年-2029年） - アジア太平洋の生物製剤滅菌充填仕上げサービス市場規模（2018年-2029年） - 中国の生物製剤滅菌充填仕上げサービス市場規模（2018年-2029年） - 日本の生物製剤滅菌充填仕上げサービス市場規模（2018年-2029年） - 韓国の生物製剤滅菌充填仕上げサービス市場規模（2018年-2029年） - インドの生物製剤滅菌充填仕上げサービス市場規模（2018年-2029年） - オーストラリアの生物製剤滅菌充填仕上げサービス市場規模（2018年-2029年） - 中南米の生物製剤滅菌充填仕上げサービス市場規模（2018年-2029年） - 中東・アフリカの生物製剤滅菌充填仕上げサービス市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Baxter BioPharma Solutions、Boehringer Ingelheim、Vetter Pharma、Fresenius Kabi、Pfizer CentreOne、Aenova、WuXi Biologics、Jubilant HollisterStier、Bushu Pharmaceuticals、LSNE Contract Manufacturing、Ajinomoto Bio-Pharma Services、CMIC CMO、GRAM (Grand River Aseptic Manufacturing)、TAIYO Pharma Tech Co.,Ltd.、HALIX、Cognate BioServices、Afton Scientific、Novasep、Emergent BioSolutions、Seikagaku、Jiangshu YAOHAI Bio-pharmaceutical、Akron Biotech、Symbiosis Pharmaceutical Services、Techdow、Vigene Biosciences ・アナリストの観点/結論 ・調査方法とデータソース |
In pharmaceutical manufacturing, fill-finish operations are critical, since fill-finish is the last step before a product is packaged and ultimately delivered to the patient. By the time a drug reaches this stage, the drug product is highly valuable, as it has already been through labour- and cost-intensive production stages, including upstream processing, cell culture or fermentation and downstream purification. Failures in the integrity of the fill-finish stage can introduce microbial contamination and generate issues with formulation and dosing
Highlights
The global Biologics Sterile Fill-Finish Services market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Biologics Sterile Fill-Finish Services is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Biologics Sterile Fill-Finish Services is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Biologics Sterile Fill-Finish Services in Vaccines is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Biologics Sterile Fill-Finish Services include Baxter BioPharma Solutions, Boehringer Ingelheim, Vetter Pharma, Fresenius Kabi, Pfizer CentreOne, Aenova, WuXi Biologics, Jubilant HollisterStier and Bushu Pharmaceuticals, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biologics Sterile Fill-Finish Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics Sterile Fill-Finish Services.
The Biologics Sterile Fill-Finish Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Biologics Sterile Fill-Finish Services market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologics Sterile Fill-Finish Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Baxter BioPharma Solutions
Boehringer Ingelheim
Vetter Pharma
Fresenius Kabi
Pfizer CentreOne
Aenova
WuXi Biologics
Jubilant HollisterStier
Bushu Pharmaceuticals
LSNE Contract Manufacturing
Ajinomoto Bio-Pharma Services
CMIC CMO
GRAM (Grand River Aseptic Manufacturing)
TAIYO Pharma Tech Co.,Ltd.
HALIX
Cognate BioServices
Afton Scientific
Novasep
Emergent BioSolutions
Seikagaku
Jiangshu YAOHAI Bio-pharmaceutical
Akron Biotech
Symbiosis Pharmaceutical Services
Techdow
Vigene Biosciences
Segment by Type
Vials
Prefilled Syringes
Cartridges
Others
Segment by Application
Vaccines
Biologics
Biosimilar
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biologics Sterile Fill-Finish Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologics Sterile Fill-Finish Services Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Vials
1.2.3 Prefilled Syringes
1.2.4 Cartridges
1.2.5 Others
1.3 Market by Application
1.3.1 Global Biologics Sterile Fill-Finish Services Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Vaccines
1.3.3 Biologics
1.3.4 Biosimilar
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biologics Sterile Fill-Finish Services Market Perspective (2018-2029)
2.2 Biologics Sterile Fill-Finish Services Growth Trends by Region
2.2.1 Global Biologics Sterile Fill-Finish Services Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Biologics Sterile Fill-Finish Services Historic Market Size by Region (2018-2023)
2.2.3 Biologics Sterile Fill-Finish Services Forecasted Market Size by Region (2024-2029)
2.3 Biologics Sterile Fill-Finish Services Market Dynamics
2.3.1 Biologics Sterile Fill-Finish Services Industry Trends
2.3.2 Biologics Sterile Fill-Finish Services Market Drivers
2.3.3 Biologics Sterile Fill-Finish Services Market Challenges
2.3.4 Biologics Sterile Fill-Finish Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biologics Sterile Fill-Finish Services Players by Revenue
3.1.1 Global Top Biologics Sterile Fill-Finish Services Players by Revenue (2018-2023)
3.1.2 Global Biologics Sterile Fill-Finish Services Revenue Market Share by Players (2018-2023)
3.2 Global Biologics Sterile Fill-Finish Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biologics Sterile Fill-Finish Services Revenue
3.4 Global Biologics Sterile Fill-Finish Services Market Concentration Ratio
3.4.1 Global Biologics Sterile Fill-Finish Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologics Sterile Fill-Finish Services Revenue in 2022
3.5 Biologics Sterile Fill-Finish Services Key Players Head office and Area Served
3.6 Key Players Biologics Sterile Fill-Finish Services Product Solution and Service
3.7 Date of Enter into Biologics Sterile Fill-Finish Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologics Sterile Fill-Finish Services Breakdown Data by Type
4.1 Global Biologics Sterile Fill-Finish Services Historic Market Size by Type (2018-2023)
4.2 Global Biologics Sterile Fill-Finish Services Forecasted Market Size by Type (2024-2029)
5 Biologics Sterile Fill-Finish Services Breakdown Data by Application
5.1 Global Biologics Sterile Fill-Finish Services Historic Market Size by Application (2018-2023)
5.2 Global Biologics Sterile Fill-Finish Services Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Biologics Sterile Fill-Finish Services Market Size (2018-2029)
6.2 North America Biologics Sterile Fill-Finish Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Biologics Sterile Fill-Finish Services Market Size by Country (2018-2023)
6.4 North America Biologics Sterile Fill-Finish Services Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biologics Sterile Fill-Finish Services Market Size (2018-2029)
7.2 Europe Biologics Sterile Fill-Finish Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Biologics Sterile Fill-Finish Services Market Size by Country (2018-2023)
7.4 Europe Biologics Sterile Fill-Finish Services Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biologics Sterile Fill-Finish Services Market Size (2018-2029)
8.2 Asia-Pacific Biologics Sterile Fill-Finish Services Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Biologics Sterile Fill-Finish Services Market Size by Region (2018-2023)
8.4 Asia-Pacific Biologics Sterile Fill-Finish Services Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biologics Sterile Fill-Finish Services Market Size (2018-2029)
9.2 Latin America Biologics Sterile Fill-Finish Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Biologics Sterile Fill-Finish Services Market Size by Country (2018-2023)
9.4 Latin America Biologics Sterile Fill-Finish Services Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biologics Sterile Fill-Finish Services Market Size (2018-2029)
10.2 Middle East & Africa Biologics Sterile Fill-Finish Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Biologics Sterile Fill-Finish Services Market Size by Country (2018-2023)
10.4 Middle East & Africa Biologics Sterile Fill-Finish Services Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Baxter BioPharma Solutions
11.1.1 Baxter BioPharma Solutions Company Detail
11.1.2 Baxter BioPharma Solutions Business Overview
11.1.3 Baxter BioPharma Solutions Biologics Sterile Fill-Finish Services Introduction
11.1.4 Baxter BioPharma Solutions Revenue in Biologics Sterile Fill-Finish Services Business (2018-2023)
11.1.5 Baxter BioPharma Solutions Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Detail
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Biologics Sterile Fill-Finish Services Introduction
11.2.4 Boehringer Ingelheim Revenue in Biologics Sterile Fill-Finish Services Business (2018-2023)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Vetter Pharma
11.3.1 Vetter Pharma Company Detail
11.3.2 Vetter Pharma Business Overview
11.3.3 Vetter Pharma Biologics Sterile Fill-Finish Services Introduction
11.3.4 Vetter Pharma Revenue in Biologics Sterile Fill-Finish Services Business (2018-2023)
11.3.5 Vetter Pharma Recent Development
11.4 Fresenius Kabi
11.4.1 Fresenius Kabi Company Detail
11.4.2 Fresenius Kabi Business Overview
11.4.3 Fresenius Kabi Biologics Sterile Fill-Finish Services Introduction
11.4.4 Fresenius Kabi Revenue in Biologics Sterile Fill-Finish Services Business (2018-2023)
11.4.5 Fresenius Kabi Recent Development
11.5 Pfizer CentreOne
11.5.1 Pfizer CentreOne Company Detail
11.5.2 Pfizer CentreOne Business Overview
11.5.3 Pfizer CentreOne Biologics Sterile Fill-Finish Services Introduction
11.5.4 Pfizer CentreOne Revenue in Biologics Sterile Fill-Finish Services Business (2018-2023)
11.5.5 Pfizer CentreOne Recent Development
11.6 Aenova
11.6.1 Aenova Company Detail
11.6.2 Aenova Business Overview
11.6.3 Aenova Biologics Sterile Fill-Finish Services Introduction
11.6.4 Aenova Revenue in Biologics Sterile Fill-Finish Services Business (2018-2023)
11.6.5 Aenova Recent Development
11.7 WuXi Biologics
11.7.1 WuXi Biologics Company Detail
11.7.2 WuXi Biologics Business Overview
11.7.3 WuXi Biologics Biologics Sterile Fill-Finish Services Introduction
11.7.4 WuXi Biologics Revenue in Biologics Sterile Fill-Finish Services Business (2018-2023)
11.7.5 WuXi Biologics Recent Development
11.8 Jubilant HollisterStier
11.8.1 Jubilant HollisterStier Company Detail
11.8.2 Jubilant HollisterStier Business Overview
11.8.3 Jubilant HollisterStier Biologics Sterile Fill-Finish Services Introduction
11.8.4 Jubilant HollisterStier Revenue in Biologics Sterile Fill-Finish Services Business (2018-2023)
11.8.5 Jubilant HollisterStier Recent Development
11.9 Bushu Pharmaceuticals
11.9.1 Bushu Pharmaceuticals Company Detail
11.9.2 Bushu Pharmaceuticals Business Overview
11.9.3 Bushu Pharmaceuticals Biologics Sterile Fill-Finish Services Introduction
11.9.4 Bushu Pharmaceuticals Revenue in Biologics Sterile Fill-Finish Services Business (2018-2023)
11.9.5 Bushu Pharmaceuticals Recent Development
11.10 LSNE Contract Manufacturing
11.10.1 LSNE Contract Manufacturing Company Detail
11.10.2 LSNE Contract Manufacturing Business Overview
11.10.3 LSNE Contract Manufacturing Biologics Sterile Fill-Finish Services Introduction
11.10.4 LSNE Contract Manufacturing Revenue in Biologics Sterile Fill-Finish Services Business (2018-2023)
11.10.5 LSNE Contract Manufacturing Recent Development
11.11 Ajinomoto Bio-Pharma Services
11.11.1 Ajinomoto Bio-Pharma Services Company Detail
11.11.2 Ajinomoto Bio-Pharma Services Business Overview
11.11.3 Ajinomoto Bio-Pharma Services Biologics Sterile Fill-Finish Services Introduction
11.11.4 Ajinomoto Bio-Pharma Services Revenue in Biologics Sterile Fill-Finish Services Business (2018-2023)
11.11.5 Ajinomoto Bio-Pharma Services Recent Development
11.12 CMIC CMO
11.12.1 CMIC CMO Company Detail
11.12.2 CMIC CMO Business Overview
11.12.3 CMIC CMO Biologics Sterile Fill-Finish Services Introduction
11.12.4 CMIC CMO Revenue in Biologics Sterile Fill-Finish Services Business (2018-2023)
11.12.5 CMIC CMO Recent Development
11.13 GRAM (Grand River Aseptic Manufacturing)
11.13.1 GRAM (Grand River Aseptic Manufacturing) Company Detail
11.13.2 GRAM (Grand River Aseptic Manufacturing) Business Overview
11.13.3 GRAM (Grand River Aseptic Manufacturing) Biologics Sterile Fill-Finish Services Introduction
11.13.4 GRAM (Grand River Aseptic Manufacturing) Revenue in Biologics Sterile Fill-Finish Services Business (2018-2023)
11.13.5 GRAM (Grand River Aseptic Manufacturing) Recent Development
11.14 TAIYO Pharma Tech Co.,Ltd.
11.14.1 TAIYO Pharma Tech Co.,Ltd. Company Detail
11.14.2 TAIYO Pharma Tech Co.,Ltd. Business Overview
11.14.3 TAIYO Pharma Tech Co.,Ltd. Biologics Sterile Fill-Finish Services Introduction
11.14.4 TAIYO Pharma Tech Co.,Ltd. Revenue in Biologics Sterile Fill-Finish Services Business (2018-2023)
11.14.5 TAIYO Pharma Tech Co.,Ltd. Recent Development
11.15 HALIX
11.15.1 HALIX Company Detail
11.15.2 HALIX Business Overview
11.15.3 HALIX Biologics Sterile Fill-Finish Services Introduction
11.15.4 HALIX Revenue in Biologics Sterile Fill-Finish Services Business (2018-2023)
11.15.5 HALIX Recent Development
11.16 Cognate BioServices
11.16.1 Cognate BioServices Company Detail
11.16.2 Cognate BioServices Business Overview
11.16.3 Cognate BioServices Biologics Sterile Fill-Finish Services Introduction
11.16.4 Cognate BioServices Revenue in Biologics Sterile Fill-Finish Services Business (2018-2023)
11.16.5 Cognate BioServices Recent Development
11.17 Afton Scientific
11.17.1 Afton Scientific Company Detail
11.17.2 Afton Scientific Business Overview
11.17.3 Afton Scientific Biologics Sterile Fill-Finish Services Introduction
11.17.4 Afton Scientific Revenue in Biologics Sterile Fill-Finish Services Business (2018-2023)
11.17.5 Afton Scientific Recent Development
11.18 Novasep
11.18.1 Novasep Company Detail
11.18.2 Novasep Business Overview
11.18.3 Novasep Biologics Sterile Fill-Finish Services Introduction
11.18.4 Novasep Revenue in Biologics Sterile Fill-Finish Services Business (2018-2023)
11.18.5 Novasep Recent Development
11.19 Emergent BioSolutions
11.19.1 Emergent BioSolutions Company Detail
11.19.2 Emergent BioSolutions Business Overview
11.19.3 Emergent BioSolutions Biologics Sterile Fill-Finish Services Introduction
11.19.4 Emergent BioSolutions Revenue in Biologics Sterile Fill-Finish Services Business (2018-2023)
11.19.5 Emergent BioSolutions Recent Development
11.20 Seikagaku
11.20.1 Seikagaku Company Detail
11.20.2 Seikagaku Business Overview
11.20.3 Seikagaku Biologics Sterile Fill-Finish Services Introduction
11.20.4 Seikagaku Revenue in Biologics Sterile Fill-Finish Services Business (2018-2023)
11.20.5 Seikagaku Recent Development
11.21 Jiangshu YAOHAI Bio-pharmaceutical
11.21.1 Jiangshu YAOHAI Bio-pharmaceutical Company Detail
11.21.2 Jiangshu YAOHAI Bio-pharmaceutical Business Overview
11.21.3 Jiangshu YAOHAI Bio-pharmaceutical Biologics Sterile Fill-Finish Services Introduction
11.21.4 Jiangshu YAOHAI Bio-pharmaceutical Revenue in Biologics Sterile Fill-Finish Services Business (2018-2023)
11.21.5 Jiangshu YAOHAI Bio-pharmaceutical Recent Development
11.22 Akron Biotech
11.22.1 Akron Biotech Company Detail
11.22.2 Akron Biotech Business Overview
11.22.3 Akron Biotech Biologics Sterile Fill-Finish Services Introduction
11.22.4 Akron Biotech Revenue in Biologics Sterile Fill-Finish Services Business (2018-2023)
11.22.5 Akron Biotech Recent Development
11.23 Symbiosis Pharmaceutical Services
11.23.1 Symbiosis Pharmaceutical Services Company Detail
11.23.2 Symbiosis Pharmaceutical Services Business Overview
11.23.3 Symbiosis Pharmaceutical Services Biologics Sterile Fill-Finish Services Introduction
11.23.4 Symbiosis Pharmaceutical Services Revenue in Biologics Sterile Fill-Finish Services Business (2018-2023)
11.23.5 Symbiosis Pharmaceutical Services Recent Development
11.24 Techdow
11.24.1 Techdow Company Detail
11.24.2 Techdow Business Overview
11.24.3 Techdow Biologics Sterile Fill-Finish Services Introduction
11.24.4 Techdow Revenue in Biologics Sterile Fill-Finish Services Business (2018-2023)
11.24.5 Techdow Recent Development
11.25 Vigene Biosciences
11.25.1 Vigene Biosciences Company Detail
11.25.2 Vigene Biosciences Business Overview
11.25.3 Vigene Biosciences Biologics Sterile Fill-Finish Services Introduction
11.25.4 Vigene Biosciences Revenue in Biologics Sterile Fill-Finish Services Business (2018-2023)
11.25.5 Vigene Biosciences Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details